Circulating miR-10b-5p, miR-193a-3p, and miR-1-3p Are Deregulated in Patients with Heart Failure and Correlate with

Anna Maria Grimaldi1, Roberta D'Assante2, Francesco Fiore2

  • 1IRCCS SYNLAB SDN, Via Emanuele Gianturco 113, 80143 Naples, Italy.

Insights

Circulating microRNAs (miRNAs) like miR-10b-5p, miR-193a-5p, and miR-1-3p can detect heart failure (HF) patients, especially those with multiple hormonal deficiencies (MHDS). These miRNAs are downregulated in HF and correlate with hormonal status, aiding in HF diagnosis.

Area of Science:

  • Endocrinology
  • Cardiology
  • Molecular Biology

Background:

  • Heart failure (HF) is a major global health burden.
  • Anabolic hormonal axis reduction is implicated in HF progression.
  • MicroRNAs (miRNAs) play roles in endocrine function and HF detection.

Purpose of the Study:

  • To explore the association between circulating miRNA profiles and multiple hormonal deficiencies in HF patients.
  • To provide new insights into HF pathophysiology.
  • To assess the diagnostic potential of miRNAs in HF with hormonal deficiencies.

Main Methods:

  • Plasma samples from 129 subjects (94 HF patients, 35 controls) were analyzed.
  • Circulating miRNAs (miR-1-3p, miR-10b-5p, miR-24-3p, miR-193a-5p, miR-454-3p, miR-503-5p, miR-551b-3p, miR-598-3p) were measured.
  • Hormone levels (IGF-1, fT3, DHEA-S, testosterone), NT-proBNP, HF subtypes, and NYHA class were evaluated. Multiple hormonal deficiency syndrome (MHDS) defined as ≥2 deficiencies.

Main Results:

  • miR-10b-5p, miR-193a-5p, and miR-1-3p distinguished HF patients from controls.
  • These miRNAs were downregulated in HF patients, particularly those with NYHA I-II and elevated NT-proBNP.
  • The three miRNAs correlated with each other and were influenced by hormone deficiencies, especially in reduced ejection fraction patients.
  • miR-10b-5p showed the highest diagnostic accuracy for chronic HF-MHDS patients (AUC = 0.8).

Conclusions:

  • Circulating miR-10b-5p, miR-193a-5p, and miR-1-3p are potential biomarkers for detecting HF.
  • These miRNAs are particularly useful in identifying HF patients with co-existing hormonal deficiencies.
  • The findings support the clinical utility of these miRNAs in understanding HF pathophysiology and diagnosis.

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
405
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
69
Hormonal Regulation of Blood Pressure01:17

Hormonal Regulation of Blood Pressure

Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
2.5K
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
352